Position in ANAB
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,139,750
+$609,056 QoQ
Shares Held
31,700
-23.4% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 211 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. ANAB ranks #107 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
717,440 | $356,373,971 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
293,020 | $182,709,690 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
374,080 | $112,609,302 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
456,331 | $85,461,669 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,159,800 | $65,029,986 | |
| 6 | INSM |
INSMED Inc
|
593,512 | $63,280,249 | |
| 7 | INCY |
Incyte Corp
|
476,874 | $54,058,436 | |
| 8 | MRNA |
Moderna, Inc.
|
679,900 | $47,613,397 |
All Filings in ANAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,139,750 | 31,700 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,530,694 | 27,600 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,338,048 | 27,600 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $869,606 | 28,400 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $586,080 | 26,400 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $602,314 | 32,400 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $393,229 | 29,700 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $887,748 | 26,500 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $526,261 | 21,000 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $472,918 | 21,000 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $561,204 | 26,200 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $680,682 | 37,900 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $866,484 | 42,600 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $802,945 | 36,900 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,267,491 | 40,900 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,022,953 | 40,100 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $793,728 | 39,100 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,046,499 | 42,300 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,362,201 | 39,200 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,063,104 | 39,200 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,016,457 | 39,200 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,198,182 | 55,600 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,195,397 | 55,600 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $805,347 | 54,600 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,219,761 | 54,600 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $669,762 | 47,400 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||